Trelegy Ellipta
Last Reviewed: Nov 15, 2024
Drug Details
Generic Name:
Fluticasone furoate, umeclidinium bromide, vilanterol trifenatate
Common Brands:
Availability:
Prescription only
Therapeutic Class:
Inhaled corticosteroid (ICS), long-acting muscarinic antagonist (LAMA) or anticholinergic, and long-acting beta 2 adrenergic agonist (LABA)
Forms:
Inhalation powder
Administration:
By oral inhalation using a special inhaler
Therapeutic Uses:
- Maintenance treatment of bronchial asthma
- Maintenance treatment of chronic obstructive pulmonary diseases (COPD)
Controlled Status:
Not a controlled substance
Trelegy Ellipta Drug Class
Trelegy Ellipta (treh-leh-jee ell-ip-tah) contains three medications - fluticasone which belongs to a group of drugs called inhaled corticosteroids (ICS), umeclidinium which belongs to a group of drugs called long-acting muscarinic antagonists (LAMA) or anticholinergics, and vilanterol which belongs to a group of drugs called long acting beta-2 adrenergic agonists (LABA).
Trelegy Ellipta Age Range
Trelegy Ellipta (fluticasone, umeclidinium, vilanterol) is approved for use in adults. The safety and efficacy of this combination inhaler have not been established in people under the age of 18 years.
SOCIAL